Nutex Health Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
NUTX$194.16+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| | December 31, | |||||
| · · 2024 · · 2023 | ||||||
| Assets | | | | | | |
| Current assets: | | | | | | |
| Cash and cash equivalents | | $43,581,412 | | $22,002,056 | ||
| Accounts receivable | | 232,449,226 | | 58,624,301 | ||
| Accounts receivable - related parties | | 3,602,189 | | 4,152,068 | ||
| Inventories | | 2,849,814 | | 3,390,584 | ||
| Prepaid expenses and other current assets | | 9,996,244 | | 2,679,394 | ||
| Total current assets | | | 292,478,885 | | | 90,848,403 |
| Property and equipment, net | | | 77,932,744 | | | 81,387,649 |
| Operating right-of-use assets | | | 27,871,830 | | | 11,853,082 |
| Financing right-of-use assets | | 218,889,351 | | 176,146,329 | ||
| Intangible assets, net | | | 15,530,281 | | | 20,512,636 |
| Goodwill, net | | 13,918,719 | | 17,066,263 | ||
| Deferred tax assets | | | 7,987,236 | | | - |
| Other assets | | | 711,347 | | | 431,135 |
| | | | | | | |
| Total assets | | $655,320,393 | | $398,245,497 | ||
| | | | | | | |
| Liabilities and Equity | | | ||||
| Current liabilities: | | | ||||
| Accounts payable | | $9,613,821 | | $18,899,196 | ||
| Accounts payable - related parties | | 4,345,138 | | 6,382,197 | ||
| Lines of credit | | 3,554,029 | | 3,371,676 | ||
| Current portion of long-term debt | | 14,395,457 | | 10,808,721 | ||
| Operating lease liabilities, current portion | | | 2,079,940 | | | 1,579,987 |
| Financing lease liabilities, current portion | | | 7,704,873 | | | 4,315,979 |
| Accrued arbitration expenses | | | 47,741,815 | | | - |
| Accrued income tax expense | | | 25,989,262 | | | - |
| Accrued expenses and other current liabilities | | | 25,441,790 | | 12,955,296 | |
| Total current liabilities | | 140,866,125 | | 58,313,052 | ||
| Long-term debt, net | | | 22,465,896 | | | 26,314,733 |
| Operating lease liabilities, net | | | 30,617,399 | | | 15,479,639 |
| Financing lease liabilities, net | | | 259,479,096 | | | 213,886,213 |
| Deferred tax liabilities | | | - | | | 5,145,754 |
| Total liabilities | | 453,428,516 | | 319,139,391 | ||
| | | | | | | |
| Commitments and contingencies (Note 10) | | | | | | |
| | | | | | | |
| Equity: | | | | | | |
| Common stock, $0.001 par value; 950,000,000 shares authorized; 5,511,452 and 4,511,199 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively | | | 5,511 | | | 4,511 |
| Additional paid-in capital | | | 503,232,609 | | | 470,521,218 |
| Accumulated deficit | | | (356,893,371) | | | (409,072,539) |
| Nutex Health Inc. equity | | | 146,344,749 | | | 61,453,190 |
| Noncontrolling interests | | 55,547,128 | | | 17,652,916 | |
| Total equity | | | 201,891,877 | | | 79,106,106 |
| | | | | | | |
| Total liabilities and equity | | $655,320,393 | | $398,245,497 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.